Literature DB >> 5596183

Antiprotozoan and antibacterial activity of 2-nitroimidazole derivatives.

E Grunberg, G Beskid, R Cleeland, W F DeLorenzo, E Titsworth, H J Scholer, R Richle, Z Brener.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5596183

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics of Benznidazole in Healthy Volunteers and Implications in Future Clinical Trials.

Authors:  I Molina; F Salvador; A Sánchez-Montalvá; M A Artaza; R Moreno; L Perin; A Esquisabel; L Pinto; J L Pedraz
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

2.  Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase.

Authors:  F S Buckner; C L Verlinde; A C La Flamme; W C Van Voorhis
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

Review 3.  Critical analysis of Chagas disease treatment in different countries.

Authors:  Fernanda de Souza Nogueira Sardinha Mendes; Jose Antonio Perez-Molina; Andrea Angheben; Sheba K Meymandi; Sergio Sosa-Estani; Israel Molina
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-07-08       Impact factor: 2.747

4.  Effects of l-(2-nitro-l-imidazolyl)-3-methoxy-2-propanol and 2-methyl-5-nitroimidazole-l-ethanol against anaerobic and aerobic bacteria and protozoa.

Authors:  H N Prince; E Grunberg; E Titsworth; W F DeLorenzo
Journal:  Appl Microbiol       Date:  1969-11

Review 5.  Experimental and Clinical Treatment of Chagas Disease: A Review.

Authors:  Policarpo Ademar Sales Junior; Israel Molina; Silvane Maria Fonseca Murta; Adrián Sánchez-Montalvá; Fernando Salvador; Rodrigo Corrêa-Oliveira; Cláudia Martins Carneiro
Journal:  Am J Trop Med Hyg       Date:  2017-10-10       Impact factor: 2.345
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.